Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Safe-BioPharma Association

Safe-BioPharma Association?uq=8lCq2teR
2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Developer of digital identity and signature standard designed to provide global, enhanced assurance identity trust for cyber-transactions. The company's digital identity and signature standard offers a secure, enforceable and regulatory-compliant way to verify digital identities and to apply digital signatures in electronic transactions, eliminates paper works and improves business processes, enabling biopharmaceutical industries to mitigates legal, regulatory and other business risk associated with electronic transactions.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Security Services (B2B)
Other Industries
Application Software
Parent Company
National Health Information Sharing and Analysis Center
Primary Office
  • 82 North Summit Street
  • Suite 2
  • Tenafly, NJ 07670
  • United States

+1 (903) 000-0000

Safe-BioPharma Association Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Safe-BioPharma Association‘s full profile, request access.

Request full access to PitchBook

Safe-BioPharma Association Executive Team (3)

Name Title Board
Seat
Contact
Info
Peter Alterman Ph.D Chief Operating Officer, Operations & Chief Policy Officer
Gary Secrest Chief Technology Officer, Technology & Board Member

1 Former Executive

You’re viewing 2 of 3 executives. Get the full list »

Safe-BioPharma Association Board Members (1)

Name Representing Role Since Contact
Info
0000 0000000 Safe-BioPharma Association Chief Technology Officer, Technology & Board Member 000 0000